News
Pulmonary fibrosis drug developer Avalyn files IPO
Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies.
News
23andMe study explains variable results with obesity drugs
Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.
News
Syneron raises $150m for macrocyclics, and other financings
Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.
News
Jeito closes 'record' $1.2bn Europe-focused biopharma fund
Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.
R&D
Sponsored
A data-driven guide to small molecule drug discovery and dev...
A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
